Cynthia J. Ladd

Cynthia J. Ladd has filed trades across 2 companies (mainly through SEC (Form 4)), most often in MyoKardia, Inc. and CytomX Therapeutics, Inc. We count 3 filings; the first trade dates from 14 October 2015 and the latest from 6 January 2020.

In open-market terms, that means 1 purchase worth €31k on one side and 1 sale worth €113k on the other. On balance, insiders were net sellers of €82k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 option exercise. In 2020 alone, the filings show no purchases and 1 sale.

On 7 January 2020 came the latest disclosure, an open-market sale for €113k in MyoKardia, Inc. The last insider purchase was made public on 16 October 2015, 4,042 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.